- Home
- BCRX vs MCRI Comparison
BCRX vs MCRI Comparison
Compare BCRX & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | MCRI |
|---|---|---|
| Founded | 1986 | 1972 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BCRX | MCRI |
|---|---|---|
| Price | $7.24 | $93.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | $20.82 | ★ $100.50 |
| AVG Volume (30 Days) | ★ 4.2M | 118.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.21 | $4.85 |
| Revenue Next Year | $6.13 | $2.21 |
| P/E Ratio | ★ N/A | $17.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.00 | $69.99 |
| 52 Week High | $11.31 | $113.88 |
Technical Indicators
Market Signals| Indicator | BCRX | MCRI |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 52.19 |
| Support Level | $6.26 | $92.25 |
| Resistance Level | $6.91 | $101.07 |
| Average True Range (ATR) | 0.27 | 3.22 |
| MACD | 0.10 | 0.14 |
| Stochastic Oscillator | 97.13 | 51.69 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.